ERBB2 and breast cancer: Furthermore, in the ex vivo assay using freshly isolated human breast cancer tissues (ER+/PR+/HER2- and ER+/PR-/HER2-), BM CM significantly shrank the fragment size in 3 days (Figure 3E).